These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 16980074)
61. High-dose intravenous immunoglobulin and rituximab treatment for antibody-mediated rejection after kidney transplantation: a cost analysis. Tanriover B; Wright SE; Foster SV; Roush KS; Castillo-Lugo JA; Fa K; Levy FL; Mejia A Transplant Proc; 2008 Dec; 40(10):3393-6. PubMed ID: 19100397 [TBL] [Abstract][Full Text] [Related]
62. Renal lesions in essential mixed IgG-IgM cryoglobulinemia. Study of 48 cases. Barbiano di Belgiojoso G; Bertoli S; Tarantino A; Colasanti G; Bosisio-Bestetti M; Ferrario F; Montagnino G; Banfi G; Bucci A; Surian M; Colussi G; Guerra L; Micoli G Boll Ist Sieroter Milan; 1981; 60(4):316-27. PubMed ID: 7034747 [TBL] [Abstract][Full Text] [Related]
63. Rituximab as a therapeutic tool in severe mixed cryoglobulinemia. Roccatello D; Baldovino S; Rossi D; Giachino O; Mansouri M; Naretto C; Di Simone D; Francica S; Cavallo R; Alpa M; Napoli F; Sena LM Clin Rev Allergy Immunol; 2008 Feb; 34(1):111-7. PubMed ID: 18270864 [TBL] [Abstract][Full Text] [Related]
64. Response to rituximab in patients with type II cryoglobulinemia. Bryce AH; Dispenzieri A; Kyle RA; Lacy MQ; Rajkumar SV; Inwards DJ; Yasenchak CA; Kumar SK; Gertz MA Clin Lymphoma Myeloma; 2006 Sep; 7(2):140-4. PubMed ID: 17026826 [TBL] [Abstract][Full Text] [Related]
65. Serum sickness associated with rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia. Catuogno M; Rezai S; Priori R; Magrini L; Valesini G Rheumatology (Oxford); 2005 Mar; 44(3):406. PubMed ID: 15637037 [No Abstract] [Full Text] [Related]
66. Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al. De Vita S; Quartuccio L Arthritis Rheum; 2010 Mar; 62(3):908-9; author reply 909. PubMed ID: 20131242 [No Abstract] [Full Text] [Related]
67. Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab. Petrarca A; Rigacci L; Monti M; Giannini C; Bernardi F; Caini P; Colagrande S; Bosi A; Laffi G; Zignego AL Dig Liver Dis; 2007 Sep; 39 Suppl 1():S129-33. PubMed ID: 17936214 [TBL] [Abstract][Full Text] [Related]
68. [Mixed cryoglobulinemia with monoclonal IgA and biclonal IgM during hepatitis C virus infection]. Abdi S; Bahji M; Essaadouni L; Agoumi N; Adnaoui M; Tazi ZM; Maaouni A Ann Biol Clin (Paris); 2004; 62(3):334-7. PubMed ID: 15217768 [TBL] [Abstract][Full Text] [Related]
69. Successful renal transplantation to a recipient with type II cryoglobulinemia: a case report. Kasagi T; Nobata H; Ikeda K; Banno S; Ito Y BMC Nephrol; 2018 Jul; 19(1):170. PubMed ID: 29986657 [TBL] [Abstract][Full Text] [Related]
70. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Zaja F; De Vita S; Mazzaro C; Sacco S; Damiani D; De Marchi G; Michelutti A; Baccarani M; Fanin R; Ferraccioli G Blood; 2003 May; 101(10):3827-34. PubMed ID: 12560225 [TBL] [Abstract][Full Text] [Related]
71. Renal diseases in 18 patients with mixed type II IgM-IgG cryoglobulinemia: monoclonal lymphoid infiltration (2 cases) and membranoproliferative glomerulonephritis (14 cases). Cordonnier D; Vialtel P; Renversez JC; Chenais F; Favre M; Tournoud A; Barioz C; Bayle F; Dechelette E; Denis MC; Couderc P Adv Nephrol Necker Hosp; 1983; 12():177-204. PubMed ID: 6404134 [No Abstract] [Full Text] [Related]
72. Rituximab inefficiency during type I cryoglobulinaemia. Nehme-Schuster H; Korganow AS; Pasquali JL; Martin T Rheumatology (Oxford); 2005 Mar; 44(3):410-1. PubMed ID: 15657071 [No Abstract] [Full Text] [Related]
73. [Mixed idiopathic cryoglobulinemia and glomerulonephritis (author's transl)]. Reumont G; Hillemand B; Godin M; Dero M Sem Hop; 1980 Oct; 56(37-38):1531-5. PubMed ID: 6254177 [TBL] [Abstract][Full Text] [Related]
74. [Risk factors of progression in cryoglobulinemic glomerulonephritis associated with hepatitis C virus]. Kozlovskaia LV; Mukhin NA; Gordovskaia NB; Malyshko EIu; Varshavskiĭ VA; Ignatova TM; Konstantinova NA Klin Med (Mosk); 2001; 79(4):32-5. PubMed ID: 11496735 [TBL] [Abstract][Full Text] [Related]
75. Cryoglobulinaemia: clinical features and response to treatment. Singer DR; Venning MC; Lockwood CM; Pusey CD Ann Med Interne (Paris); 1986; 137(3):251-3. PubMed ID: 3767196 [TBL] [Abstract][Full Text] [Related]
76. Lymphoproliferative disease-related mixed cryoglobulinemia treated with rituximab and prednisolone. Shimamura Y; Takizawa H; Ogawa Y; Sakai H; Ryu A; Moniwa N; Hasegawa K; Ura N CEN Case Rep; 2015 May; 4(1):6-13. PubMed ID: 28509274 [TBL] [Abstract][Full Text] [Related]
77. Hepatitis C virus infection and rituximab therapy after renal transplantation. Fabrizi F; Martin P; Elli A; Montagnino G; Banfi G; Passerini P; Campise MR; Tarantino A; Ponticelli C Int J Artif Organs; 2007 May; 30(5):445-9. PubMed ID: 17551909 [TBL] [Abstract][Full Text] [Related]
78. Cold agglutinin disease and cryoglobulinemia. Gertz MA Clin Lymphoma; 2005 Mar; 5(4):290-3. PubMed ID: 15794868 [TBL] [Abstract][Full Text] [Related]
79. Cryoglobulinaemia type III with severe neuropathy and immune complex glomerulonephritis: remission after plasmapheresis and rituximab. Braun A; Neumann T; Oelzner P; Hein G; Gröne HJ; Ziemer M; Wolf G Rheumatol Int; 2008 Mar; 28(5):503-6. PubMed ID: 17924113 [TBL] [Abstract][Full Text] [Related]
80. Safety and efficacy of rituximab treatment for vasculitis in hepatitis B virus-associated type II cryoglobulinemia: a case report. Pasquet F; Combarnous F; Macgregor B; Coppere B; Mausservey C; Ninet J; Hot A J Med Case Rep; 2012 Jan; 6():39. PubMed ID: 22284897 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]